|
Additional information was provided in a.1., a.2., a.3.A., b.5., b.6., b.3., d.1., d.2., d.3., d.4., d.6.A., d.10.,h.3., h.6.And h.11.The product was not returned.Complaint and product history records were reviewed and documentation indicated the product met release criteria.The product investigation could not identify a root cause for the reported complaint.The lens remains implanted.Each lens is subjected to a 100percentage assessment of the power and optical resolution during the manufacturing process in order to determine acceptability per the lens model and diopter.Information was provided that the vision in the right eye (b)(4), which has had a yag capsulotomy has improved to 0.0 logmar unaided for distance and n5 unaided for near following a lasik enhancement procedure in january.As a result, surgeon is not considering explanting the lens from the left eye (which has not yet had a yag capsulotomy).The glistenings look symmetrical and now that the refraction has been optimized in the right eye the patient is happy with the vision in that eye.The surgeon indicated that it would be safer to optimize the left eye with a yag capsulotomy plus or minus lasik rather than explant the lens.File will be reopened if new information is received related to the treatment for the left.The manufacturer internal reference number is: (b)(4).H.10 reflects all related report numbers associated with this product event that have been submitted at this time.
|